GentleWave vs. Waterlase for Root Canal Treatment
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two new techniques, GentleWave and Waterlase, to determine if they outperform the usual method for root canal treatment. Researchers aim to discover if these techniques improve healing in cases of infections or bone loss around the tooth root. Participants will receive either one of the new treatments or the usual one and will be monitored for a year to assess tooth healing. Suitable candidates have a permanent tooth needing a root canal and show signs of tooth nerve problems or bone loss on X-rays. As an unphased trial, this study allows participants to contribute to innovative dental research and potentially benefit from advanced treatment options.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Previous studies showed that the GentleWave System had a 97.3% success rate in treating root canals, with healing rates over 97% at 6 and 12 months. Patients experienced short-term pain levels similar to traditional methods, indicating good tolerance.
Research shows that the Waterlase iPlus effectively cleans and disinfects root canals. It uses laser technology to fight infections, providing dentists with better control during the procedure.
Both treatments are promising, with high success rates and manageable pain levels, suggesting they are safe options for root canal treatment.12345Why are researchers excited about this trial's treatments?
Researchers are excited about the GentleWave System and Waterlase iPlus for root canal treatments because they offer innovative approaches to endodontic irrigation. Unlike traditional methods that often rely on manual techniques, the GentleWave System uses advanced acoustic energy to clean and disinfect the root canal system more thoroughly, potentially leading to better long-term healing. On the other hand, Waterlase iPlus employs laser technology, which not only aids in cleaning but also minimizes discomfort and accelerates the healing process. These cutting-edge technologies could significantly enhance the effectiveness and patient experience compared to the conventional treatments like passive ultrasonic irrigation.
What evidence suggests that the GentleWave System and Waterlase iPlus are effective for root canal treatment?
In this trial, participants will receive either the GentleWave System or Waterlase iPlus for root canal treatments. Research has shown that the GentleWave System is highly effective, with a success rate of over 97%, and typically causes less discomfort during and after the procedure. This system excels at cleaning root canals, promoting faster healing. Meanwhile, studies on Waterlase iPlus have demonstrated its effectiveness in reducing bacteria and debris in the root canal. This laser treatment cleans deeply and lessens the need for strong chemicals. Both treatments offer promising alternatives to traditional methods, aiming for better results and increased comfort.12467
Who Is on the Research Team?
Glenn Karunanayake, BDS, MS
Principal Investigator
University of North Carolina, Chapel Hill
Are You a Good Fit for This Trial?
This trial is for males and females aged 14-99 with a permanent tooth needing root canal treatment due to pulp disease or infection, who can consent to the procedure. It's not for those with teeth that can't be restored, have high mobility or deep periodontal pockets, fractures, open apices, certain anatomical challenges, need multiple RCTs, allergies to anesthetics or severe systemic diseases.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive endodontic treatment using either GentleWave, Waterlase, or passive ultrasonic irrigation. Treatment may be completed in one or two appointments.
Follow-up
Participants are monitored for clinical and radiographic healing of periapical lesions over 12 months.
What Are the Treatments Tested in This Trial?
Interventions
- GentleWave System
- Waterlase iPlus
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor